Dysregulation of PP2A is a key driver of cancer development, most often arising from copy number variations (CNV), imbalances in regulatory proteins (SET and CIP2A), or PTMs rather than recurrent hotspot mutations. The gene discussed is PTPA; the disease is cancer.